Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Hedge funds cut exposure across strategies

Tuesday, June 26, 2012

Bailey McCann, Opalesque, New York: Hedge funds cut exposure across strategies this month, according to new research from Bank of America Merrill Lynch Global Research. According to Mary Ann Bartels, hedge fund analyst at BofA, Market Neutral funds aggressively cut market exposure to 1% from 12% net long. Equity Long/Short sold market exposure further to 26% from 30% net long. Macros partially added to their shorts in the S&P 500, NASDAQ 100, EM, EAFE, commodities and 10-year Treasuries futures, while continuing to buy USD.

Merger Arbitrage and Long/Short performed the best, up 0.29% and 0.20%, respectively. CTA Advisors performed the worst, down 2.60%. Long/Short funds continue with defensive moves - going after large cap picks over style and quality. In futures, large funds more than tripled their positions in NASDAQ 100 futures. Funds continued to short soybean, wheat and corn. Funds are buying gold again after a few weeks of selling out of their positions.

In currencies, the Euro remains a crowded short. The Dollar remains on an upward trend despite a small sell off. Funds are also buying the Yen. The investable hedge fund composite index was down 0.16% for the month as of June 20, compared to up 3.46% for the S&P 500.

......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its